secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001601830-24-000005
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion Pharmaceuticals releases updated investor presentation for JPM Healthcare Conference
--------------------------------------------------------------------------------

- Presentation released on January 8, 2024, for use at JPM Healthcare Conference and investor meetings.
- No specific financial or pipeline details available from the provided exhibit text.
- Filing marked as Regulation FD disclosure; not deemed filed for SEC liability purposes.
- Exhibit only includes title page and a fragment of legal disclaimer; full content not accessible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000005/0001601830-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000005/rxrx-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer